PH-sensitive pullulan-based nanoparticle carrier for adriamycin to overcome drug-resistance of cancer cells

Carbohydrate Polymers

Volumn 111, Issue , 2014, Pages 908-917

  Guo, Hua ^a   Liu, Yuanyuan ^a   Wang, Yinsong ^a   Wang, Yan ^a   Wu, Jing ^a,b   Yang, Xiaoying ^a   Li, Rongshan ^a   Zhang, Ning ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b TIANJIN THIRD CENTRAL HOSPITAL   (China)

Author keywords

Cancer; Drug resistance; Nanoparticle carrier; O Urocanyl pullulan; pH sensitive

Indexed keywords

CELLS; CYTOLOGY; DRUG THERAPY; NANOPARTICLES;

CANCER; DEGREE OF SUBSTITUTION; DRUG RELEASE MECHANISM; DRUG RESISTANCE; MCF-7/ADR CELLS; PH SENSITIVE; PULLULANS; SPHERICAL SHAPE;

PHARMACODYNAMICS;

ANTINEOPLASTIC ANTIBIOTIC; DELAYED RELEASE FORMULATION; DOXORUBICIN; GLUCAN; NANOPARTICLE; PULLULAN;

BREAST; BREAST NEOPLASMS; CHEMISTRY; DELAYED RELEASE FORMULATION; DRUG EFFECTS; DRUG RESISTANCE; FEMALE; HUMAN; MCF 7 CELL LINE; PATHOLOGY; PH;

ANTIBIOTICS, ANTINEOPLASTIC; BREAST; BREAST NEOPLASMS; DELAYED-ACTION PREPARATIONS; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GLUCANS; HUMANS; HYDROGEN-ION CONCENTRATION; MCF-7 CELLS; NANOPARTICLES;

EID: 84902155920     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2014.05.057     Document Type: Article

References (40)

1. F. Alexis, E. Pridgen, L.K. Molnar, and O.C. Farokhzad Factors affecting the clearance and biodistribution of polymeric nanoparticles Molecular Pharmaceutics 5 4 2008 505 515
2. Y. Bae, S. Fukushima, A. Harada, and K. Kataoka Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change Angewandte Chemie International Edition 42 38 2003 4640 4643
3. E. Blanco, C.W. Kessinger, B.D. Sumer, and J. Gao Multifunctional micellar nanomedicine for cancer therapy Experimental Biology and Medicine (Maywood, N.J.) 234 2 2009 123 131
4. C.-H. Choi ABC transporters as multidrug resistance mechanisms and the development of chemosensitizers for their reversal Cancer Cell International 5 1 2005 30
5. R.G. Deeley, C. Westlake, and S.P. Cole Transmembrane transport of endo-and xenobiotics by mammalian ATP-binding cassette multidrug resistance proteins Physiological Reviews 86 3 2006 849 899
6. X. Dong, and R.J. Mumper Nanomedicinal strategies to treat multidrug-resistant tumors: Current progress Nanomedicine 5 4 2010 597 615
7. A.-M. Florea, and D. Büsselberg Cisplatin as an anti-tumor drug: Cellular mechanisms of activity, drug resistance and induced side effects Cancers 3 2011 1351 1371
8. E. Fox, and S.E. Bates Tariquidar (XR9576): A P-glycoprotein drug efflux pump inhibitor Expert Review of Anticancer Therapy 7 4 2007 447 459
9. R. Gowda, N.R. Jones, S. Banerjee, and G.P. Robertson Use of nanotechnology to develop multi-drug inhibitors for cancer therapy Journal of Nanomedicine & Nanotechnology 4 6 2013 1000184
10. M.M. Gottesman, T. Fojo, and S.E. Bates Multidrug resistance in cancer: Role of ATP-dependent transporters Nature Reviews Cancer 2 1 2002 48 58
11. M. Gupta, and A.K. Gupta Hydrogel pullulan nanoparticles encapsulating pBUDLacZ plasmid as an efficient gene delivery carrier Journal of Controlled Release 99 1 2004 157 166
12. S. Hariharan, S. Gunda, G.P. Mishra, D. Pal, and A.K. Mitra Enhanced corneal absorption of erythromycin by modulating P-glycoprotein and MRP mediated efflux with corticosteroids Pharmaceutical Research 26 5 2009 1270 1282
13. Y. Kaneo, T. Tanaka, T. Nakano, and Y. Yamaguchi Evidence for receptor-mediated hepatic uptake of pullulan in rats Journal of Controlled Release 70 3 2001 365 373
14. N. Kartner, and V. Ling Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines Science 221 4617 1983 1285 1288
15. D. Kim, E.S. Lee, K.T. Oh, Z.G. Gao, and Y.H. Bae Doxorubicin-loaded polymeric micelle overcomes multidrug resistance of cancer by double-targeting folate receptor and early endosomal pH Small 4 11 2008 2043 2050
16. K.-I. Kiyomiya, S. Matsuo, and M. Kurebe Mechanism of specific nuclear transport of adriamycin the mode of nuclear translocation of adriamycin-proteasome complex Cancer Research 61 6 2001 2467 2471
17. E.S. Lee, Z. Gao, and Y.H. Bae Recent progress in tumor pH targeting nanotechnology Journal of Controlled Release 132 3 2008 164 170
18. S.D. Li, and L. Huang Pharmacokinetics and biodistribution of nanoparticles Molecular Pharmaceutics 5 4 2008 496 504
19. H. Li, L. Hui, W. Xu, H. Shen, Q. Chen, and L. Long et al. Modulation of P-glycoprotein expression by triptolide in adriamycin-resistant K562/A02 cells Oncology Letters 3 2 2012 485 489
20. Z. Liu, Y. Jiao, Y. Wang, C. Zhou, and Z. Zhang Polysaccharides-based nanoparticles as drug delivery systems Advanced Drug Delivery Reviews 60 15 2008 1650 1662
21. L. Milane, S. Ganesh, S. Shah, Z.F. Duan, and M. Amiji Multi-modal strategies for overcoming tumor drug resistance: Hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology Journal of Controlled Release 155 2 2011 237 247
22. K. Na, E.S. Lee, and Y.H. Bae Adriamycin loaded pullulan acetate/sulfonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro Journal of Controlled Release 87 1 2003 3 13
23. K. Na, E.S. Lee, and Y.H. Bae Self-organized nanogels responding to tumor extracellular pH: pH-dependent drug release and in vitro cytotoxicity against MCF-7 cells Bioconjugate Chemistry 18 2007 1568 1574
24. K.T. Oh, H.J. Baik, A.H. Lee, Y.T. Oh, Y.S. Youn, and E.S. Lee The reversal of drug-resistance in tumors using a drug-carrying nanoparticular system International Journal of Molecular Sciences 10 9 2009 3776 3792
25. T. Ozben Mechanisms and strategies to overcome multiple drug resistance in cancer FEBS Letters 580 12 2006 2903 2909
26. D. Peer, J.M. Karp, S. Hong, O.C. Farokhzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nature Nanotechnology 2 12 2007 751 760
27. P. Peng, F. Peng, J. Bian, F. Xu, and R. Sun Studies on the starch and hemicelluloses fractionated by graded ethanol precipitation from bamboo phyllostachys bambusoides f. shouzhu Yi Journal of Agricultural and Food Chemistry 59 6 2011 2680 2688
28. A. Persidis Cancer multidrug resistance Nature Biotechnology 17 1 1999 94 95
29. A. Stavrovskaya Cellular mechanisms of multidrug resistance of tumor cells Biochemistry (Moscow) 65 1 2000 95 106
30. M.A. Summers, J.L. Moore, and J.W. McAuley Use of verapamil as a potential P-glycoprotein inhibitor in a patient with refractory epilepsy The Annals of Pharmacotherapy 38 10 2004 1631 1634
31. H.B. Tang, L. Li, H. Chen, Z.M. Zhou, H.L. Chen, and X.-M. Li et al. Stability and in vivo evaluation of pullulan acetate as a drug nanocarrier Drug Delivery 17 7 2010 552 558
32. H. Thomas, and H.M. Coley Overcoming multidrug resistance in cancer: An update on the clinical strategy of inhibiting p-glycoprotein Cancer Control: Journal of the Moffitt Cancer Center 10 2 2003 159
33. Y. Wang, H. Chen, Y. Liu, J. Wu, P. Zhou, and Y. Wang et al. pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma Biomaterials 34 2013 7181 7190
34. Y. Wang, M. Guo, Y. Lu, L.Y. Ding, W.T. Ron, and Liu et al. Alpha-tocopheryl polyethylene glycol succinate-emulsified poly(lactic-co- glycolic acid) nanoparticles for reversal of multidrug resistance in vitro Nanotechnology 23 2012 495103
35. Y.S. Wang, Q. Jiang, R.S. Li, L.L. Liu, Q.Q. Zhang, and Y.M. Wang et al. Self-assembled nanoparticles of cholesterol-modified O-carboxymethyl chitosan as a novel carrier for paclitaxel Nanotechnology 19 14 2008 145101
36. Y.S. Wang, L.R. Liu, Q. Jiang, and Q.Q. Zhang Self-aggregated nanoparticles of cholesterol-modified chitosan conjugate as a novel carrier of epirubicin European Polymer Journal 43 1 2007 43 51
37. Y. Yan, C.J. Ochs, G.K. Such, J.K. Heath, E.C. Nice, and F. Caruso Bypassing multidrug resistance in cancer cells with biodegradable polymer capsules Advanced Materials 22 47 2010 5324 5403
38. D.A. Yardley Drug Resistance and the role of combination chemotherapy in improving patient outcomes International Journal of Breast Cancer 2013 2013 137414
39. W. Yinsong, L. Lingrong, W. Jian, and Q. Zhang Preparation and characterization of self-aggregated nanoparticles of cholesterol-modified O-carboxymethyl chitosan conjugates Carbohydrate Polymers 69 3 2007 597 606
40. N. Zhang, P.R. Wardwell, and R.A. Bader Polysaccharide-based micelles for drug delivery Pharmaceutics 5 2 2013 329 352